This compound is a pharmaceutical intermediate used in the manufacturing of saxagliptin. It is supplied as a salt form for research and development purposes.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 361440-69-9
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride
Pharmaceutical intermediate for drug synthesis
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide
active pharmaceutical ingredient
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide
dipeptidyl peptidase-4 inhibitor intermediate
(2S)-((tert-Butoxycarbonyl)amino)(3-hydroxytricyclo(3.3.1.1 3,7)dec-1-yl)acetic acid
Pharmaceutical intermediate for peptide synthesis
1,1-Dimethylethyl N-((1S)-2-((1S,3S,5S)-3-(aminocarbonyl)-2-azabicyclo(3.1.0)hex-2-yl)-1-(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)-2-oxoethyl)carbamate
saxagliptin intermediate
5-chlorothiophene-3-carboxylic acid
Pharmaceutical intermediate for Avatrombopag synthesis
Ethyl 4-hydroxycyclohexanecarboxylate
pharmaceutical intermediate
(1R,3S,5R)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE
research compound for chemical studies
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide;2,2,2-trifluoroacetic acid
ANTLFTRMIBAQHA-SHLRHQAISA-N
C1[C@@H]2[C@H]1N[C@@H](C2)C(=O)N.C(=O)(C(F)(F)F)O